Case Study #5 | Ivy Tree Advisors

Market Entry Strategy: AI for Biopharma R&D

Shaping the Future of Pharma: Leveraging AI to Meet Unmet Needs in Drug Research & Development

Objective: Develop a product offering that addresses the unmet needs across different Pharma R&D segments, leveraging AI and real-world data to enhance drug development lifecycle.
Activities and Deliverables:
- Conducted comprehensive market evaluations, including interviews with prospective buyers within Pharma and analyses of partnerships and capabilities, to understand the unmet needs in Pharma R&D.
- Synthesized inputs from primary and secondary research, combined with existing expertise, to prioritize and articulate pathways for commercialization, focusing on AI's role in population management and R&D.
- Initiated a new client relationship with a top 3 Pharma company and secured a significant follow-on investment based on the developed product offering and the insights gained from customer development feedback.

An AI company specializing in digital health for Pharma R&D, had initial success in population management and sought to expand its impact across the R&D sector.
Conducted an evaluation of several customer segments and interviewed prospective buyers within Pharma, alongside an extensive market landscape analysis, including partnerships and capabilities comparisons.
Aimed to leverage its early successes to further penetrate the Pharma R&D market, addressing unmet needs through advanced AI applications.

Develop a product offering tailored to meet the diverse and unmet needs of different Pharma segments throughout the drug development lifecycle.
Conduct an extensive market landscape evaluation, including in-depth interviews with 10 experts in AI and real-world data from target Pharma companies.
Identify and articulate the best pathways to commercialize the AI capabilities in serving the specific needs of Pharma R&D segments.

Synthesized inputs from primary and secondary research, integrating findings with the company's existing expertise in digital health and AI.
Prioritized the development of a commercial strategy that leverages the company’s strengths in population management and AI to serve Pharma R&D.
Engaged with prospective buyers and industry experts to refine and validate the proposed product offerings and commercial pathways.

Successfully initiated a new client relationship with a top 3 Pharma company, demonstrating the value of the AI-driven solutions for R&D.
Secured a major follow-on investment based on the strength of the customer development feedback and the articulated commercial strategy.
Positioned the client as a key player in transforming Pharma R&D with AI, leading to expanded market opportunities and strategic partnerships.

Elevated client's market positioning as a pioneer in integrating AI into Pharma R&D, showcasing the potential to revolutionize drug development through data-powered digital health solutions.
Opened new avenues for the company by proving its capability to meet diverse and critical unmet needs within the Pharma industry, thus broadening its client base and enhancing its product offerings.
Facilitated a paradigm shift in how Pharma companies approach R&D, with client's AI solutions at the forefront, fostering innovation, and setting new standards for efficiency and effectiveness in the drug development process.